Cheng‐Hong Tsai

1.6k total citations
65 papers, 691 citations indexed

About

Cheng‐Hong Tsai is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Cheng‐Hong Tsai has authored 65 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 30 papers in Genetics and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Cheng‐Hong Tsai's work include Acute Myeloid Leukemia Research (38 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (25 papers) and Lymphoma Diagnosis and Treatment (10 papers). Cheng‐Hong Tsai is often cited by papers focused on Acute Myeloid Leukemia Research (38 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (25 papers) and Lymphoma Diagnosis and Treatment (10 papers). Cheng‐Hong Tsai collaborates with scholars based in Taiwan, United States and Australia. Cheng‐Hong Tsai's co-authors include Hsin‐An Hou, Hwei‐Fang Tien, Wen‐Chien Chou, Chien‐Chin Lin, Jih‐Luh Tang, Ming Yao, Mei‐Hsuan Tseng, Yuan‐Yeh Kuo, Feng‐Ming Tien and Chia‐Wen Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Cheng‐Hong Tsai

56 papers receiving 684 citations

Peers

Countries citing papers authored by Cheng‐Hong Tsai

Since Specialization

Citations

This map shows the geographic impact of Cheng‐Hong Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Hong Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Hong Tsai more than expected).

Fields of papers citing papers by Cheng‐Hong Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Hong Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Hong Tsai. The network helps show where Cheng‐Hong Tsai may publish in the future.

Co-authorship network of co-authors of Cheng‐Hong Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Hong Tsai. A scholar is included among the top collaborators of Cheng‐Hong Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Hong Tsai. Cheng‐Hong Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Annotation-free deep learning for predicting gene mutations from whole slide images of acute myeloid leukemia 2025 ·npj Precision Oncology ·(unknown), Cheng‐Hong Tsai, (unknown), (unknown), (unknown), Wen‐Chien Chou, Hwei‐Fang Tien, Hsin‐An Hou, Chien‐Yu Chen	2
2	Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations 2024 ·Blood Cancer Journal ·Feng‐Ming Tien, Chi‐Yuan Yao, Cheng‐Hong Tsai, (unknown), Chien‐Yuan Chen, (unknown), Chien‐Chin Lin, Yuan‐Yeh Kuo, Yen‐Ling Peng, Mei‐Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang‐In Lin, (unknown), Bor‐Sheng Ko, Ming Yao, Jih‐Luh Tang, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	8
3	Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes 2024 ·Blood Advances ·Chi‐Yuan Yao, Chien‐Chin Lin, (unknown), (unknown), Cheng‐Hong Tsai, Hsin‐An Hou, (unknown), Chia‐Lang Hsu, Wen‐Chien Chou	3
4	Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms 2024 ·Blood Cancer Journal ·(unknown), Chien‐Chin Lin, Cheng‐Hong Tsai, Feng‐Ming Tien, (unknown), Mei‐Hsuan Tseng, Yuan‐Yeh Kuo, (unknown), Ming-Chih Liu, Chang‐Tsu Yuan, (unknown), (unknown), Bor‐Sheng Ko, Jih‐Luh Tang, (unknown), (unknown), Hwei‐Fang Tien, Hsin‐An Hou, Wen‐Chien Chou	7
5	Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification 2023 ·Blood Cancer Journal ·(unknown), (unknown), Cheng‐Hong Tsai, Feng‐Ming Tien, (unknown), Mei‐Hsuan Tseng, Yuan‐Yeh Kuo, Ming-Chih Liu, (unknown), (unknown), Jih‐Luh Tang, (unknown), (unknown), Liang‐In Lin, Wen‐Chien Chou, Chien‐Chin Lin, Hsin‐An Hou, Hwei‐Fang Tien	12
6	Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML 2023 ·Blood Cancer Journal ·Cheng‐Hong Tsai, (unknown), (unknown), Feng‐Ming Tien, Yuan‐Yeh Kuo, Mei‐Hsuan Tseng, Yen‐Ling Peng, (unknown), Bor‐Sheng Ko, Jih‐Luh Tang, (unknown), Ming-Chih Liu, Chia‐Wen Liu, Chien‐Chin Lin, Ming Yao, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	17
7	Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification 2023 ·American Journal of Hematology ·(unknown), Chien‐Chin Lin, Cheng‐Hong Tsai, Feng‐Ming Tien, (unknown), (unknown), Ming Yao, Mei‐Hsuan Tseng, Yuan‐Yeh Kuo, (unknown), Jih‐Luh Tang, (unknown), (unknown), Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	6
8	Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification 2023 ·Blood ·(unknown), (unknown), Chien‐Chin Lin, Cheng‐Hong Tsai, Feng‐Ming Tien, (unknown), Mei‐Hsuan Tseng, Yuan‐Yeh Kuo, (unknown), Ming-Chih Liu, Chang‐Tsu Yuan, (unknown), (unknown), Jih‐Luh Tang, (unknown), (unknown), Hsin‐An Hou, Hwei‐Fang Tien, Wen‐Chien Chou	1
9	Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia 2023 ·American Journal of Hematology ·(unknown), Cheng‐Hong Tsai, Chien‐Chin Lin, Feng‐Ming Tien, Yuan‐Yeh Kuo, (unknown), Yen‐Ling Peng, (unknown), Mei‐Hsuan Tseng, (unknown), (unknown), Liang‐In Lin, (unknown), (unknown), Bor‐Sheng Ko, Jih‐Luh Tang, Ming Yao, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	19
10	Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma 2023 ·Cancer Medicine ·Chieh‐Lung Cheng, Po‐Ting Yeh, (unknown), Weili Ma, Hsin‐An Hou, Cheng‐Hong Tsai, Chang‐Ping Lin, Hwei‐Fang Tien	4
11	Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients 2022 ·SHILAP Revista de lepidopterología ·(unknown), Chi‐Yuan Yao, Chien‐Chin Lin, Chi‐Ling Chen, Chia‐Lang Hsu, Cheng‐Hong Tsai, Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien	4
12	Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry 2022 ·Cancers ·Cheng‐Hong Tsai, Tzu‐Ting Chen, Jyh‐Pyng Gau, Po‐Nan Wang, Yi‐Chang Liu, (unknown), Chi‐Cheng Li, Ming Yao, Bor‐Sheng Ko	7
13	Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome 2021 ·British Journal of Haematology ·(unknown), Chien‐Chin Lin, Chi‐Yuan Yao, Chia‐Lang Hsu, Cheng‐Hong Tsai, Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien	3
14	Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML 2021 ·Blood Advances ·Cheng‐Hong Tsai, Jih‐Luh Tang, Feng‐Ming Tien, Yuan‐Yeh Kuo, (unknown), Chien‐Chin Lin, Mei‐Hsuan Tseng, Yen‐Ling Peng, (unknown), (unknown), Ming-Chih Liu, Chia‐Wen Liu, Ming Yao, Liang‐In Lin, Wen‐Chien Chou, Chien‐Yu Chen, Hsin‐An Hou, Hwei‐Fang Tien	38
15	Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax 2020 ·Annals of Hematology ·Yuwen Wang, Cheng‐Hong Tsai, Chien‐Chin Lin, Feng‐Ming Tien, Yu‐Wen Chen, (unknown), Ming Yao, (unknown), Chien‐Ting Lin, Chieh‐Lung Cheng, Jih‐Luh Tang, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	55
16	A child with juvenile myelomonocytic leukemia possessing a concurrent germline CBL mutation and a NF1 variant of uncertain significance: A rare case with a common problem in the era of high-throughput sequencing 2020 ·Journal of the Formosan Medical Association ·(unknown), Meng‐Yao Lu, Cheng‐Hong Tsai, (unknown), (unknown), Shiann‐Tarng Jou	0
17	Use of Machine Learning in 2074 Cases of Acute Myeloid Leukemia for Genetic Risk Profiling 2019 ·Blood ·Shaun Fleming, Cheng‐Hong Tsai, Hartmut Döhner, Konstanze Döhner, Elli Papaemmanuil, Hwei‐Fang Tien, John Reynolds, Andrew H. Wei, Hsin‐An Hou	9
18	Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients 2019 ·EBioMedicine ·Cheng‐Hong Tsai, Chi‐Yuan Yao, (unknown), Jih‐Luh Tang, Yuan‐Yeh Kuo, Yu‐Chiao Chiu, Chien‐Chin Lin, Mei‐Hsuan Tseng, Yen‐Ling Peng, Ming-Chih Liu, Chia‐Wen Liu, Ming Yao, Liang‐In Lin, Wen‐Chien Chou, Chien‐Yu Chen, Hsin‐An Hou, Hwei‐Fang Tien	26
19	The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome 2018 ·Blood Cancer Journal ·(unknown), Yu‐Chiao Chiu, (unknown), Hsin‐An Hou, Chien‐Chin Lin, Cheng‐Hong Tsai, Mei‐Hsuan Tseng, Wen‐Chien Chou, Hwei‐Fang Tien	20
20	Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome 2018 ·EBioMedicine ·Bor‐Sheng Ko, Yu‐Fen Wang, (unknown), Chi‐Cheng Li, (unknown), Szu-Chun Hsu, Hsin‐An Hou, Huai‐Hsuan Huang, Ming Yao, Chien‐Ting Lin, Jia‐Hau Liu, Cheng‐Hong Tsai, Tai‐Chung Huang, Shang‐Ju Wu, Shang‐Yi Huang, Wen‐Chien Chou, Hwei‐Fang Tien, Chi-Chun Lee, Jih‐Luh Tang	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact